First of all is EGID (European Genomic Institute for Diabetes) an international research institute focused on diabetes (type 1 and 2), obesity and its associated risk factors.

The fundamental mission of the institute will be to develop mayor breakthroughs in the understanding of these diseases, as well as their diagnosis and therapeutic treatments.


EGID'scope are simple : fundamental research, university education, permanent education, prevention, prediction, clinical applications, industrial valorisation and promotion of public health actions.


EGID is destined to play a major role worldwide in the field of diabetes, obesity and its associated factors.